Abstract We determined quantitative and qualitative alterations in lipids during the occurrence and progression of spinal cord injury (SCI) in rats to identify potential clinical indicators of SCI pathology. Imaging mass spectrometry (IMS) was used to visualize twelve molecular species of phosphatidylcholine (PC) on thin slices of spinal cord with SCI. In addition, twelve species of phospholipids and five species of prostaglandins (PGs) were quantified by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) of lipid extracts from control/injured spinal cords. Unique distribution patterns were observed for phospholipids with different fatty acid compositions, and distinct dynamic changes were seen in both their amounts and their distributions in tissue as tissue damage resulting from SCI progressed. In particular, PCs containing docosahexaenoic acid localized to the large nucleus in the anterior horn region at one day post-SCI and rapidly decreased thereafter. In contrast, PCs containing arachidonic acid (AA-PCs) were normally found in the posterior horn region and were intensely and temporarily elevated one week after SCI. Lysophosphatidylcholines (LPCs) also increased at the same SCI stage and in regions with elevated AA-PCs, indicating the release of AA and the production of PGs. Moreover, LC-ESI-MS/MS analysis of lipid extracts from the spinal cord tissue at the impact site demonstrated a peak in PGE2 that reflected the elevation/reduction pattern of AA-PCs and LPC. Although further investigation is required, we suggest that invasive immune cells that penetrated from the impaired blood-brain barrier at 1-2 weeks post-SCI may have produced LPCs, released AA from AA-PCs, and produced PGs in SCI tissue at sites enriched in AA-PCs/LPC.
in regulating the physical properties of cellular membranes [1] [2] [3] [4] [5] and in transmitting signals via the production of bioactive lipids such as prostaglandins (PGs) [1, 6, 7] . Alterations in lipid metabolism may play an important role in neurological disorders and CNS injury. Indeed, levels of several lipids are strongly correlated with the occurrence and progression of tissue disorganization due to spinal cord injury (SCI), which results from an initial trauma followed by a degenerative process. Severe inflammation found in injured spinal cord [8, 9] was associated with bioactive lipids, including PGs produced by invasive immune cells. Similarly, elevated levels of the lysophospholipid group in SCI were also observed [10, 11] , highlighting the importance of lipid dynamics in tissue inflammation [10] [11] [12] [13] .
Lipid research has traditionally focused on the biochemical quantification of lipids in fluid samples of cellular or tissue extracts to elucidate numerous physiologically important roles of lipids. However, the emerging lipid molecular imaging technology, imaging mass spectrometry (IMS) allows spatially resolved imaging of lipids, and provides qualitative information on lipid distribution in situ [14] . Furthermore, the integration of quantitative techniques [e.g., liquid chromatography or gas chromatography coupled to MS or tandem mass spectrometry (MS/MS)] with qualitative methods such as IMS provides researchers with the tools needed to quantify the amount of lipid molecules produced by specific cells in situ.
In particular, IMS incorporating matrix-assisted laser desorption/ionization (MALDI) is a powerful and practical tool in lipid research [10, [14] [15] [16] [17] . The unique advantages of IMS include the following: (i) simultaneous detection of multiple lipids in the same specimen, which has shown that slight structural differences in lipid molecules produce a heterogeneous distribution pattern in biological tissues [13, 14, [18] [19] [20] ; (ii) application to a wide range of analytes [21] , ranging from small and simple to large and more complex lipids such as glycolipids with complex oligosaccharide moieties [22, 23] ; (iii) a simple and fast protocol [17] . In fact, using SCI model rats, a recent study by Cooks' group found that specific lipid species accumulated in the lesion epicenter and adjacent areas after SCI [13] .
The introduction of IMS into classical lipid research is a frontier issue because, both qualitative and quantitative analyses are necessary in medical/biological research in order to understand complex biological phenomena and their regulation (i.e., the regulation of local concentrations of biomolecules in subcellular organelles up to the tissue substructure level). RNAs are routinely localized using in situ hybridization and quantitative real-time PCR with oligonucleotide probes, whereas proteins are localized by immunostaining methods and quantified by western blotting with antibodies. In this context, we and other groups have integrated MALDI-IMS with liquid chromatography-electrospray ionization-MS/MS (LC-ESI-MS/MS) in order to identify specific tissue regions or the cellular production of specific lipids in situ [18, 24] . However, given the complex nature of biological tissue samples that have not been subjected to analyte purification, numerous competing endogenous ion peaks are present in each spectrum acquired by MALDI-IMS. Both LC-resolved lipid identification (based on MS/MS scanning data) [26] and quantification data (based on multiple reaction monitoring [MRM] data) [25, 27] can enhance the data obtained by IMS.
Therefore, an improved understanding of the molecular mechanism of lipid pathophysiology involved in SCI may be achieved through the integrated use of qualitative and quantitative lipid analyses, which may also lead to the discovery of efficient therapies. The aim of the present study was to quantitatively and qualitatively examine alterations in lipids during the occurrence and progression of SCI in order to identify potential clinical indicators that may be used to evaluate SCI pathology.
Materials and methods

Chemicals
Methanol, potassium acetate, and ultrapure water were purchased from Wako Chemicals (Osaka, Japan). Calibrationstandard peptide and 2,5-dihydroxybenzoic acid (DHB) were purchased from Bruker Daltonics (Leipzig, Germany), and 9-aminoacridine was purchased from Acronics (Pittsburgh, PA, USA). All of the chemicals used in this study were of the highest purity available.
Abbreviations for glycerophospholipids
The structures of the side chains of gycerophospholipid species with one or two radyl side chains are indicated within parentheses in the "headgroup(coupling scheme/sn1/sn2)" format [e.g., PC(diacyl-16:0/18:1)].
Animals
All experiments were performed according to the guidelines for animal experimentation and the care and use of laboratory animals established by Nagoya University School. Nine-weekold Sprague-Dawley rats (190-210 g) were used in this study.
Generation of SCI rats
All rats were deeply anesthetized with 25 mg/kg pentobarbital sodium. Laminectomy was performed at the ninth and tenth thoracic (T10) levels, and contusion injury of the spinal cord was introduced at level T10 using the Infinite Horizon impactor (IH impactor, 200 kdyn; Precision Systems and Instrumentation, Lexington, NY, USA). After contusion injury, the laminectomy was closed by suturing the muscle with nylon, followed by the use of wound clips to close the skin incision site. Rats with SCI at the site of injury were sacrificed 12 h (hours); 1 d (day); or 1, 2, or 8 w (weeks) post-SCI.
Tissue preparation
Rats were anesthetized with 25 mg/kg pentobarbital sodium and sacrificed by transcardial perfusion with cold PBS, and the spinal cords of rats with SCI were extracted (approximately 2 cm in length around the SCI). Similarly, the spinal cords of rats without SCI were also extracted (approximately 2 cm in length around the T10-level cord). Immediately after dissection, the spinal cords were flash frozen in dry ice and stored in a deep freezer at −80°C. Spinal cord tissues were divided into four sections of thickness 5 mm from the proximal to the distal side of the SCI site.
Overall experimental procedure
An outline of the experimental procedure employing MALDI-IMS and LC-ESI-MS/MS to analyze alterations in the lipids in the spinal cords of rats with SCI is shown inFig. S1 of the "Electronic supplementary material" (ESM) . Dissected rat spinal cords with/without SCI treatment were sectioned into four tissue blocks (from the proximal to the distal side) and stored at −80°C until further use. For IMS, each frozen block was thinly sliced in a cryo-chamber, and the residual blocks were used for LC-ESI-MS/MS. Spatial alterations of lipids between different tissue locations and time points after SCI were explored by IMS. The relative abundance of phospholipids and the absolute abundance of PGs in lipid extracts from tissue blocks were quantified by LC-ESI-MS/MS.
IMS sample preparation
The 5 mm tissue sections were sliced to a thickness of 8 μm with a cryostat (CM1950; Leica, Wetzler, Germany), placed directly onto MALDI plate inserts, and stored at 20°C until matrix application and subsequent IMS analysis.
Spray coating of the matrix solution for IMS
A DHB solution (40 mg/mL DHB, 20 mM potassium acetate, 70% MetOH, and 0.1% TFA) was used as the matrix solution to image phosphatidylcholine (PC). The matrix solution (approximately 100 μL) was sprayed over the tissue surface using a 0.2 mm nozzle caliber airbrush (Procon Boy FWA Platinum; Mr. Hobby, Tokyo, Japan). Tissue sections for comparison were simultaneously spray coated with each matrix solution to equalize analyte the extraction and cocrystallization conditions. The distance between the nozzle tip and the tissue surface was 10 cm, and the spraying period was fixed at 5 min.
IMS conditions
Single MS imaging was performed using a MALDI TOF/TOFtype instrument (Ultraflex 2 TOF/TOF; Bruker Daltonics) equipped with a 355 nm Nd:YAG laser. The data were acquired in the positive reflectron mode under an accelerating potential of 20 kV using an external calibration method. Signals between m/z 400 and 1,000 were collected. Raster scans on tissue surfaces were performed automatically using the FlexControl and FlexImaging 2.0 software (Bruker Daltonics). The number of laser irradiations was 200 shots at each spot. Image reconstruction was performed with the FlexImaging 2.0 software.
LC-ESI-MS/MS
ESI-MS/MS analysis was performed using a 4000Q-TRAP quadrupole linear ion trap hybrid mass spectrometer (Applied Biosystems/MDS Sciex, Concord, ON, Canada) with an Acquity Ultra Performance LC (Waters, Milford, MA, USA). A chromatographic method was developed using an Acquity UPLCTM BEH C18 column (2.1×50 mm i.d., 1.7 μm particles) fitted with an identically packed guard column (2. 
Quantification of PGs
PGs in the spinal cords were quantified as described by the method of Kita et al. [28] . Briefly, the triple quadrupole mass spectrometer equipped with an ESI ion source (4000-Qtrap) was operated in negative ESI and MRM mode. For accurate quantification, an internal standard method was used that employed a mixture of deuterium-labeled PG as an internal standard.
Results and discussion
Characteristic distribution of PC molecular species in normal spinal cords IMS analysis of the spinal cord tissue of all rats revealed characteristic PC distribution patterns that depended on fatty acid composition, which reflected the heterogeneous membrane lipid compositions of distinct cell types. As shown in Fig. 1a , phospholipids in normal spinal cord sections were examined by MALDI-IMS in the positive ion detection mode. As a result, approximately 150 mass peaks in the mass range of 700<m/z< 900 were detected. Among these peaks, 14 intense mass peaks were assigned to abundant PC molecular species based on their masses and previously reported data [12] . Subsequently, LC-ESI-MS/MS was employed in MRM mode to quantify the relative composition of the 14 PC molecular species in the spinal cord block by monitoring ion transitions from intact PC ions to a fragment ion of m/z 184, which is a PC head group ion (Fig. 1b) . As can be seen from Fig. 1a and 1b, the relative abundance of each PC molecular species is in good agreement with the relative peak/height ratio observed in MALDI-IMS spectra. In addition, trace amounts of lysophosphatidylcholine (LPC) species were detected, and their relative abundances are shown (Fig. 1b, inset) .
The tissue distributions of the twelve major PC molecular species in the spinal cord section were subsequently visualized (Fig. 2) . The most abundant molecular PC species (diacyl-16:0/18:1) was uniformly distributed across the entire gray matter region of the spinal cord. However, the specific fatty acid compositions of some other species resulted in unique localization features. In particular, with the exception of the (16:0/18:1) species, PCs with oleic acid (18:1), i.e., PC (diacyl-18:0/18:1) and PC(diacyl-18:1/18:1), were frequently localized in the white matter region. Similarly, previous studies have shown that oleic acid-containing PCs are enriched in the myelin sheath structure of the CNS [16, 29, 30] . Moreover, 3-docosahexaenoic acid (DHA)-containing species, i.e., PC (diacyl-16:0/22:6), PC(diacyl-18:0/22:6), and PC(diacyl-18:1/22:6), were frequently localized to gray matter regions. In particular, the close-up distribution of PC(diacyl-16:0/ 22:6), this PC molecular specie enriched in a region of the large nucleus of motor neurons of the anterior horn, indicated that this DHA-PC was selectively produced by the motor neurons and composed their cellular membrane ( Fig. 2a, b ; arrowheads).
Irreversible reductions in DHA-containing PCs at one day after SCI Spatiotemporal changes in PCs were examined by generating relative-abundance maps on the tissue sections at different SCI stages and proximal/distal positions. Analyses were Fig. 1a-b ) performed on 24 sections from sham-operated and injured groups during a period of 12 h to 8 weeks post-SCI (n03 for each group). A total of four different cross-sections located from the proximal to the distal side, including the impact site, were assessed. As a result, we found both temporal and irreversible alterations in distinct PC molecular species, particularly for those containing polyunsaturated fatty acids (PUFAs), i.e., arachidonic acid (AA)-and DHA-containing PCs. Furthermore, PCs containing the same PUFA showed similar alteration patterns. We additionally note that the IMS results from sham-operated samples, which had been laminectomized, indicated no significant alteration in PC content except for LPC(16:0) (see Fig. S2 of the ESM). As shown in the red square, both AA-PCs showed intense increases at the impact site by 1 week post-SCI, while lower or almost no alterations were found at other tissue locations. The elevations were observed as temporary events and had resolved by 8 weeks post-SCI At the impact site, DHA-containing PCs exhibited irreversible reductions in an impact site-specific manner. This abnormal reduction began from 1 d post-SCI and evolved up to 8 weeks after SCI. The IMS results for DHA-containing PCs, i.e., PC (diacyl-16:0/22:6) and PC(diacyl-18:0/22:6), are shown in Fig. 3 . In the control samples, four proximal/distal spinal cord sections showed the aforementioned selective gray matter distribution, which remained unaltered 12 h post-SCI. However, a primary reduction was observed at 1 d after SCI, which was severe around the central canal and gray commissure. While the decreased levels at the anterior and posterior horns were initially moderate (arrowheads),the DHA-PCs were even absent from these regions at 1 week after SCI. This DHA-PC reduction is unique due to its irreversible nature; indeed, DHA-PC reductions continued to evolve at 2 and 8 weeks post-SCI. These observations are summarized in the upper panel of Fig. 5a , in which averaged ion intensities of DHA-PCs from each whole section have been calculated and represented as 3D bar charts. The semi-quantified data also support the gradual decrease in DHA-PCs from 1 week after SCI (Fig. 5, orange arrows) . The bottom panel in Fig. 5a shows extracted bar charts for the impacted site from the 3D chart, and we confirmed that the reduction in DHA-PCs-both PC(diacyl-16:0/22:6) and PC (diacyl-18:0/22:6)-between normal and 8 weeks postinjury was statistically significant (p<0.0001: normal (approx. 1300 data points) vs. 8 w (approx. 1200 data points): Welch t-test, for all three distinct animals). Given that other studies have reported the disappearance of motor neurons during the progression of SCI damage observed from 1 d after SCI , the irreversible reduction in DHA-PCs observed in the present study may result from an irreversible deficit of the neurons and could lead to motor dysfunction. Thus, DHA-PC reduction may represent a potential clinical indicator to evaluate the pathology of SCI.
Temporary elevations of AA-containing PCs after SCI
We also found that AA-containing PCs showed stage-and tissue location-specific patterns of increase. Interestingly, such elevations were temporary events that were resolved by 8 weeks post-SCI. The IMS results for two AA-PCs, i.e., PC (diacyl-16:0/20:4) and PC(diacyl-18:0/20:4), are shown in Fig. 4 . As shown in the red square, both AA-PCs showed intense increases at the impact site at 1 week post-SCI, whereas alterations at other tissue locations were minimal. These observations are summarized in the lower panel of Fig. 5b , in which averaged ion intensities of the AA-PCs from each whole section are shown. The data also demonstrate that, for both AA-PCs, the impact site exhibited the largest AA-PC signal values at 1 week after treatment, which were approximately 2.5-fold greater than in other sections at the same SCI stage. Moreover, the values gradually decreased with time after SCI. We also confirmed that the increases in the AA- Both the timing and location of the elevated AA-PCs suggest that they may be derived from invasive immune cells that penetrate into the spinal cord body thorough the impaired blood-brain barrier (BBB), which may occur as a series of spatiotemporal events following SCI. Such immune cells are known to produce several kinds of bioactive lipids, including PGs derived from AA. Indeed, there may be a greater molecular flux through the AA cascade in immune cells compared with other cells, resulting in increased AA storage in the form of AA-containing PCs in the cell membrane. Clinically, PGs produced by invasive immune cells are closely associated with inflammation [31] [32] [33] . Thus, we proceeded to conduct a detailed analysis of elevated AA-PCs as well as PG profiling.
Invasive immune cells may represent a source of elevated AA-PCs and LPCs
If invasive immune cells represent the source of elevated AA-PCs, the spatial distribution of AA-PCs should reveal co-localization with invasive cells that accumulate in areas of tissue. Therefore, we performed a detailed analysis of the AA-PC distribution in the slice containing the site of impact at 1 week after SCI (Fig. 6 ). Accurate interpretation of the lipid distribution data obtained by IMS also requires histological data and lipid ion distribution images. Therefore, we stained tissue sections with H&E after performing IMS and subsequently superimposed ion and microscopic images obtained from the same section (lower panels of Fig. 6 ). As can be seen from the upper panels in Fig. 6 , a large number of invading cell nuclei were found in tissue from the impact site (hematoxylin-positive dots), which were not seen in the proximal section. Moreover, close examination of the area indicated by arrows (also see the inset)-where immune cells were invading the spinal cord body-revealed a strong signal for the AA-PC distribution in the expected area of tissue.
We subsequently analyzed LPC molecular species, which are hydrolysates of PCs produced as by-products following the b Fig. 5a-b Semi-quantified IMS data for DHA-and AA-PCs. The 3D bar charts represent averaged ion intensities for DHA-PCs (a) and AAPCs (b) calculated from the IMS data for each whole section. These semi-quantified data support the gradual decrease of DHA-PCs at 1 week post-SCI (orange arrows). In addition, the data demonstrate that, for two AA-PCs, the impact site tissue at 1 week after treatment exhibited the largest AA-PC signal values, which were approximately 2.5-fold greater than the other sections at the same time point (red arrows). The lower panels in a and b show extracted bar charts for the impacted site from the 3D charts. Furthermore, we found that LPC(18:0) was elevated in an area that corresponded to PC(diacyl-18:0/20:4) accumulated area, while LPC was localized in a more region-specific manner (Fig. 6 , lower-right panel; arrows). LPC localized on the border areawhere the invasive cells were in contact with cells of the spinal cord body-as well as on major blood vessels. Therefore, elevated region-specific production of PGs may result in increased inflammation. Taken together, these results suggest that invasive immune cells accumulate in an area that contains both elevated AA-PC and LPC, supporting the hypothesis that AA-PC-rich immune cells produce PGs in the area of invasion-presumably at the border area where the immune cells are in contact with spinal cord cells.
PGE2 displayed an elevation pattern similar to AA-PCs and LPC Finally, we profiled PGs in the spinal cord tissue blocks in order to confirm our hypothesis that invasive immune cellsoriginating from the impaired BBB at 1-2 weeks after SCIspecifically produced PGs in the tissue area where elevated AA-PCs and LPC were co-localized. Accordingly, there may be a PG species that exhibits increases in the impact-site tissue blocks that show a similar elevation/descent pattern to the immune cell invasion event and the pattern of AA-PC/LPC elevation. Thus, we employed LC-ESI-MS/MS in MRM mode for simultaneous quantification of trace amounts of PGs. In general, PGs are produced under normal conditions and maintained at very low concentrations (on the order of pg/mg tissue) [34] , as the production, diffusion, and degradation of PGs must be regulated due to their strong bioreactivity. We found that all analyzed five PGs were increased after SCI. In particular, PGE2 showed a very similar elevation/descent pattern to that of AA-PC and LPC described above.
A 3D bar chart representing the results of PG quantification in the impact-site tissue blocks at four time points as well as the sham-operated sample is shown in Fig. 7 . All of the analyzed PGs increased following SCI, and each PG displayed characteristic elevation/descent patterns. In particular, TXB2, PGE2, and PGD2 produced the first elevation peak at 1 week post-SCI. However, while the PGE2 peak was temporary and had almost completely resolved by 2-8 weeks post-SCI, PGD2 and TXB2 exhibited a bimodal pattern, producing a second elevation at 8 weeks after SCI. In addition, PGF2a produced a single-peak elevation at 1 d after SCI, and 6-keto-PGF1a displayed a gradual increase. Since the first elevation peak for most PGs was observed at 1 week after SCI, it is likely that the invasive immune cells produce these types of PGs. Among the PGs, the dynamics of PGE2 may result from invasion and subsequent resolution, though further evidence is required to prove this concept.
PGE2 has been implicated in the induction of central sensitization of spinal neurons; therefore, information on the spatial production pattern of PGE2 in the injured spinal cord is important to determine the type and location of the neurons affected. Our data demonstrated that the maximum elevation of PGE2 occurred 1 week after SCI. However, while we were unable to directly identify where PGE2 is produced, imaging data on the more abundant AA-PCs and LPC indirectly implied that PGE2 may be produced at the edge of the area of invasive immune cells. Further improvements in IMS methodology enabling the imaging of PGs at high spatial resolution will be required to test this hypothesis.
In addition, it is possible that microglial cells contribute to PG elevation, particularly that of PGE2, since microglial cells are activated in response to primary SCI [33] and proliferate during the subacute phase. For example, obvious PGE2 elevation was observed 1 day post-injury. As microscopy did not indicate clear immune-cell invasion at this time point, we should consider the contribution of microglia to PGE2 production at this time point. Moreover, in vitro studies indicate that microglia are indeed able to synthesize and release PGE2 [35] [36] [37] [38] . Therefore, microglial PGE2 may also play an important role in the generation of central sensitization after SCI .
One method to directly determine whether invaded immune cells and activated microglia are responsible for PG elevation is to analyze the specific lipid profile of purified immune cells (including microglia) separated from SCI tissue samples. This could be achieved by combining cell sorting and quantitative mass spectrometry, which we are now implementing. Such additional in vitro experiments in which microglial cells are separately cultured and stimulated are required to evaluate the capacity of these cells for PG production.
A degree of PG elevation was maintained and had evolved at 8 weeks post-SCI. Since the invasion of immune cells was almost resolved by 8 weeks post-SCI, it is possible that SCI induced reorganization of the spinal cord body, thereby altering cellular populations and properties [33] and resulting in continuous PG production. Such tissue reorganization is likely to be caused by the subacute and severe inflammation mediated by the invasive immune cells; therefore, the profile of the five PGs analyzed in this study may be used to evaluate the stage of SCI-induced inflammation, i.e., acute vs. chronic inflammation.
Conclusion
IMS and LC-ESI MS/MS analyses revealed both quantitative and qualitative changes in lipids with respect to the amount of PCs, the LPC distribution, and the amount of PGs generated. Thus, invasive immune cells that penetrated from the impaired BBB at 1-2 weeks after SCI may have specifically produced PGs in areas of tissue where elevated AA-PCs and LPC were commonly found. Although our data demonstrated that PGE2 elevation was maximal 1 week after SCI, we were unable to directly identify where PGE2 is produced. Thus, further improvements in IMS methodology to enable the imaging of PGs are required.
